PAZOPANIB

PAZOPANIB (10042M)

pazopanib 200 mg tablet, 90
10042M
Body System:
Manner of administration:Oral
General Schedule
Authority Required (STREAMLINED)

Restriction (Streamlined authority code: 9247)

Indication: Advanced (unresectable and/or metastatic) soft tissue sarcoma
Treatment phase: Initial treatment
Quantities & Cost
Max qty packs Max qty units # of repeats DPMQ Max safety net General Patient Charge
Max qty packs: 1 Max qty units: 90 # of repeats: 2 DPMQ: $1,318.99 Max safety net: $25.00 General Patient Charge: $25.00
Available brands
Pazopanib ADVZ
Pazopanib Dr.Reddy's
Pazopanib-RZ
Votrient

PAZOPANIB (10047T)

pazopanib 200 mg tablet, 90
10047T
Body System:
Manner of administration:Oral
General Schedule
Authority Required (STREAMLINED)

Restriction (Streamlined authority code: 7458)

Indication: Advanced (unresectable and/or metastatic) soft tissue sarcoma
Treatment phase: Continuing treatment beyond 3 months
Quantities & Cost
Max qty packs Max qty units # of repeats DPMQ Max safety net General Patient Charge
Max qty packs: 1 Max qty units: 90 # of repeats: 5 DPMQ: $1,318.99 Max safety net: $25.00 General Patient Charge: $25.00
Available brands
Pazopanib ADVZ
Pazopanib Dr.Reddy's
Pazopanib-RZ
Votrient

PAZOPANIB (11252F)

pazopanib 200 mg tablet, 90
11252F
Body System:
Manner of administration:Oral
General Schedule
Authority Required (STREAMLINED)

Restriction (Streamlined authority code: 11937)

Indication: Stage IV clear cell variant renal cell carcinoma (RCC)
Treatment phase: Continuing treatment beyond 3 months
Quantities & Cost
Max qty packs Max qty units # of repeats DPMQ Max safety net General Patient Charge
Max qty packs: 1 Max qty units: 90 # of repeats: 5 DPMQ: $1,318.99 Max safety net: $25.00 General Patient Charge: $25.00
Available brands
Pazopanib ADVZ
Pazopanib Dr.Reddy's
Pazopanib-RZ
Votrient

PAZOPANIB (2029T)

pazopanib 200 mg tablet, 90
2029T
Body System:
Manner of administration:Oral
General Schedule
Authority Required (STREAMLINED)

Restriction (Streamlined authority code: 11974)

Indication: Stage IV clear cell variant renal cell carcinoma (RCC)
Treatment phase: Initial treatment
Quantities & Cost
Max qty packs Max qty units # of repeats DPMQ Max safety net General Patient Charge
Max qty packs: 1 Max qty units: 90 # of repeats: 2 DPMQ: $1,318.99 Max safety net: $25.00 General Patient Charge: $25.00
Available brands
Pazopanib ADVZ
Pazopanib Dr.Reddy's
Pazopanib-RZ
Votrient